Drawing for DEMETRA

USPTO serial 79437034

DEMETRA

Reviewed by CopyMark Law Group

Reg. 8445823Status 700Registered
Filing date
Status date
Registration date
Sep 22, 2026
Examiner
BERLIN, JUSTIN E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DEMETRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James Bitetto

James Bitetto Tutunjian & Bitetto, P.C.401 Broadhollow Road, Suite 402Melville, NY 11747United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; medical and veterinary preparations for the treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; sanitary preparations for medical use; food for babies; dietary supplements for human beings and animals; adhesive plasters for medical purposes; materials for dressings, namely, medical dressings; dental composite materials for stopping the teeth and moulding wax for dentists; disinfectants; vermin destroying preparations; fungicides; herbicides; pharmaceutical preparations for bone surgery; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; chemical preparations for pharmaceutical purposes, namely, for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; chemico-pharmaceutical preparations for the treatment of musculoskeletal disorders, septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies; veterinary preparations for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues, joint diseases and spine diseases; sanitary preparations for medical purposes; bone fillers consisting of living materials; acrylic resin for bone surgery; acrylic resin for cranioplasty and vertebroplasty; acrylic resin for neurosurgery, traumatology and orthopedics; bone cement for medical purposes; bone cement suitable for orthopedic use; bone cement suitable for veterinary purposes; bone cement with fluorine salts added for medical and veterinary purposes.ACTIVE—
010Medical apparatus and instruments for use in surgery; Medical instruments, namely, orthopedic apparatus and instruments; Surgical apparatus and instruments for medical, dental or veterinary use; artificial limbs, eyes and teeth; suture materials; massage apparatus; medical devices, instruments and apparatus for orthopedics, neurosurgery, vertebroplasty and cranioplasty namely, endorthesis screws, cannulae and connectors, trials and templates for spacers, cranial implants PMMA based; medical devices for preparing, mixing and extruding bone cement; fluid injectors for medical purposes; spacers for surgical and orthopedic use; surgical prostheses, namely, bone prostheses, joint prostheses; bone prosthesis; bone substitutes for surgical use; orthopedic articles, namely, for treatment, diagnosis and/or prevention of septic and aseptic bone, soft tissues and joint diseases, spine diseases, cranial defects, flatfoot-related pathologies.ACTIVE—
041Organization and conducting of cultural activities; training in the field of medicine; organization of seminars and conventions in the field of medicine.ACTIVE—
042Scientific research for medical purposes.ACTIVE—
044Medical services; veterinary services; hygienic and beauty care for human beings or animals.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 22, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 22, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 4, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 4, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 25, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 25, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 12, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 11, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 15, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2025DOCKASSIGNED TO EXAMINER—
Nov 16, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance